APO Research
Talk to an analyst

APO RESEARCH · REPORT

Aurora Kinase A

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Aurora Kinase A Market Analysis and Forecast 2026-2032

19 December 2025199 pages

Choose your research edition.

Industry ResearchAurora Kinase A Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Aurora Kinase A Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Aurora Kinase A Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aurora Kinase A Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Aurora Kinase A Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Aurora Kinase A market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Aurora Kinase A is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Aurora Kinase A is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Aurora Kinase A is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Aurora Kinase A is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Aurora Kinase A include Sanofi, Merck & Co., Inc., Amgen Inc., AbbVie Inc., Vichem Chemie Research Ltd., Vertex Pharmaceuticals Incorporated, Taiho Pharmaceutical Co., Ltd., Sigma-Tau S.p.A. and Sareum Holdings Plc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Aurora Kinase A, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Aurora Kinase A, also provides the sales of main regions and countries. Of the upcoming market potential for Aurora Kinase A, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Aurora Kinase A sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Aurora Kinase A market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Aurora Kinase A sales, projected growth trends, production technology, application and end-user industry.

Aurora Kinase A Segment by Company

Sanofi

Merck & Co., Inc.

Amgen Inc.

AbbVie Inc.

Vichem Chemie Research Ltd.

Vertex Pharmaceuticals Incorporated

Taiho Pharmaceutical Co., Ltd.

Sigma-Tau S.p.A.

Sareum Holdings Plc

Millennium Pharmaceuticals, Inc.

CASI Pharmaceuticals Inc.

Astex Pharmaceuticals, Inc.

Aurora Kinase A Segment by Type

AMG-900

Ilorasertib

ENMD-2076

Danusertib

Others

Aurora Kinase A Segment by Application

Brain Tumor

Ovarian Cancer

Anaplastic Large Cell Lymphoma

Others

Aurora Kinase A Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aurora Kinase A market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aurora Kinase A and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aurora Kinase A.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Aurora Kinase A in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Aurora Kinase A manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Aurora Kinase A sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Aurora Kinase A Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. AMG-900 Major Manufacturers Table 3. Ilorasertib Major Manufacturers Table 4. ENMD-2076 Major Manufacturers Table 5. Danusertib Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Aurora Kinase A Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Brain Tumor Major Manufacturers Table 9. Ovarian Cancer Major Manufacturers Table 10. Anaplastic Large Cell Lymphoma Major Manufacturers Table 11. Others Major Manufacturers Table 12. Aurora Kinase A Industry Trends Table 13. Aurora Kinase A Industry Drivers Table 14. Aurora Kinase A Industry Opportunities and Challenges Table 15. Aurora Kinase A Industry Restraints Table 16. Global Aurora Kinase A Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Aurora Kinase A Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Aurora Kinase A Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Aurora Kinase A Revenue Market Share by Region (2021-2026) Table 20. Global Aurora Kinase A Revenue Market Share by Region (2027-2032) Table 21. Global Aurora Kinase A Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 22. Global Aurora Kinase A Sales by Region (2021-2026) & (K Units) Table 23. Global Aurora Kinase A Sales by Region (2027-2032) & (K Units) Table 24. Global Aurora Kinase A Sales Market Share by Region (2021-2026) Table 25. Global Aurora Kinase A Sales Market Share by Region (2027-2032) Table 26. Global Aurora Kinase A Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Aurora Kinase A Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Aurora Kinase A Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Aurora Kinase A Sales Market Share by Manufacturers (2021-2026) Table 30. Global Aurora Kinase A Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 31. Global Aurora Kinase A Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Aurora Kinase A Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Aurora Kinase A Manufacturers, Product Type & Application Table 34. Global Aurora Kinase A Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Aurora Kinase A by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Aurora Kinase A Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Aurora Kinase A Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Aurora Kinase A Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Aurora Kinase A Revenue Market Share by Type (2021-2026) Table 41. Global Aurora Kinase A Revenue Market Share by Type (2027-2032) Table 42. Global Aurora Kinase A Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 43. Global Aurora Kinase A Sales by Type (2021-2026) & (K Units) Table 44. Global Aurora Kinase A Sales by Type (2027-2032) & (K Units) Table 45. Global Aurora Kinase A Sales Market Share by Type (2021-2026) Table 46. Global Aurora Kinase A Sales Market Share by Type (2027-2032) Table 47. Global Aurora Kinase A Price by Type (2021-2026) & (US$/Unit) Table 48. Global Aurora Kinase A Price by Type (2027-2032) & (US$/Unit) Table 49. Global Aurora Kinase A Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Aurora Kinase A Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Aurora Kinase A Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Aurora Kinase A Revenue Market Share by Application (2021-2026) Table 53. Global Aurora Kinase A Revenue Market Share by Application (2027-2032) Table 54. Global Aurora Kinase A Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 55. Global Aurora Kinase A Sales by Application (2021-2026) & (K Units) Table 56. Global Aurora Kinase A Sales by Application (2027-2032) & (K Units) Table 57. Global Aurora Kinase A Sales Market Share by Application (2021-2026) Table 58. Global Aurora Kinase A Sales Market Share by Application (2027-2032) Table 59. Global Aurora Kinase A Price by Application (2021-2026) & (US$/Unit) Table 60. Global Aurora Kinase A Price by Application (2027-2032) & (US$/Unit) Table 61. Sanofi Company Information Table 62. Sanofi Business Overview Table 63. Sanofi Aurora Kinase A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Sanofi Aurora Kinase A Product Portfolio Table 65. Sanofi Recent Development Table 66. Merck & Co., Inc. Company Information Table 67. Merck & Co., Inc. Business Overview Table 68. Merck & Co., Inc. Aurora Kinase A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Merck & Co., Inc. Aurora Kinase A Product Portfolio Table 70. Merck & Co., Inc. Recent Development Table 71. Amgen Inc. Company Information Table 72. Amgen Inc. Business Overview Table 73. Amgen Inc. Aurora Kinase A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Amgen Inc. Aurora Kinase A Product Portfolio Table 75. Amgen Inc. Recent Development Table 76. AbbVie Inc. Company Information Table 77. AbbVie Inc. Business Overview Table 78. AbbVie Inc. Aurora Kinase A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. AbbVie Inc. Aurora Kinase A Product Portfolio Table 80. AbbVie Inc. Recent Development Table 81. Vichem Chemie Research Ltd. Company Information Table 82. Vichem Chemie Research Ltd. Business Overview Table 83. Vichem Chemie Research Ltd. Aurora Kinase A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Vichem Chemie Research Ltd. Aurora Kinase A Product Portfolio Table 85. Vichem Chemie Research Ltd. Recent Development Table 86. Vertex Pharmaceuticals Incorporated Company Information Table 87. Vertex Pharmaceuticals Incorporated Business Overview Table 88. Vertex Pharmaceuticals Incorporated Aurora Kinase A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Vertex Pharmaceuticals Incorporated Aurora Kinase A Product Portfolio Table 90. Vertex Pharmaceuticals Incorporated Recent Development Table 91. Taiho Pharmaceutical Co., Ltd. Company Information Table 92. Taiho Pharmaceutical Co., Ltd. Business Overview Table 93. Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Product Portfolio Table 95. Taiho Pharmaceutical Co., Ltd. Recent Development Table 96. Sigma-Tau S.p.A. Company Information Table 97. Sigma-Tau S.p.A. Business Overview Table 98. Sigma-Tau S.p.A. Aurora Kinase A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Sigma-Tau S.p.A. Aurora Kinase A Product Portfolio Table 100. Sigma-Tau S.p.A. Recent Development Table 101. Sareum Holdings Plc Company Information Table 102. Sareum Holdings Plc Business Overview Table 103. Sareum Holdings Plc Aurora Kinase A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Sareum Holdings Plc Aurora Kinase A Product Portfolio Table 105. Sareum Holdings Plc Recent Development Table 106. Millennium Pharmaceuticals, Inc. Company Information Table 107. Millennium Pharmaceuticals, Inc. Business Overview Table 108. Millennium Pharmaceuticals, Inc. Aurora Kinase A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Millennium Pharmaceuticals, Inc. Aurora Kinase A Product Portfolio Table 110. Millennium Pharmaceuticals, Inc. Recent Development Table 111. CASI Pharmaceuticals Inc. Company Information Table 112. CASI Pharmaceuticals Inc. Business Overview Table 113. CASI Pharmaceuticals Inc. Aurora Kinase A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. CASI Pharmaceuticals Inc. Aurora Kinase A Product Portfolio Table 115. CASI Pharmaceuticals Inc. Recent Development Table 116. Astex Pharmaceuticals, Inc. Company Information Table 117. Astex Pharmaceuticals, Inc. Business Overview Table 118. Astex Pharmaceuticals, Inc. Aurora Kinase A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Astex Pharmaceuticals, Inc. Aurora Kinase A Product Portfolio Table 120. Astex Pharmaceuticals, Inc. Recent Development Table 121. North America Aurora Kinase A Revenue by Type (2021-2026) & (US$ Million) Table 122. North America Aurora Kinase A Revenue by Type (2027-2032) & (US$ Million) Table 123. North America Aurora Kinase A Sales by Type (2021-2026) & (K Units) Table 124. North America Aurora Kinase A Sales by Type (2027-2032) & (K Units) Table 125. North America Aurora Kinase A Sales Price by Type (2021-2026) & (US$/Unit) Table 126. North America Aurora Kinase A Sales Price by Type (2027-2032) & (US$/Unit) Table 127. North America Aurora Kinase A Revenue by Application (2021-2026) & (US$ Million) Table 128. North America Aurora Kinase A Revenue by Application (2027-2032) & (US$ Million) Table 129. North America Aurora Kinase A Sales by Application (2021-2026) & (K Units) Table 130. North America Aurora Kinase A Sales by Application (2027-2032) & (K Units) Table 131. North America Aurora Kinase A Sales Price by Application (2021-2026) & (US$/Unit) Table 132. North America Aurora Kinase A Sales Price by Application (2027-2032) & (US$/Unit) Table 133. North America Aurora Kinase A Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. North America Aurora Kinase A Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 135. North America Aurora Kinase A Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 136. North America Aurora Kinase A Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 137. North America Aurora Kinase A Sales by Country (2021-2026) & (K Units) Table 138. North America Aurora Kinase A Sales by Country (2027-2032) & (K Units) Table 139. North America Aurora Kinase A Sales Price by Country (2021-2026) & (US$/Unit) Table 140. North America Aurora Kinase A Sales Price by Country (2027-2032) & (US$/Unit) Table 141. United States Aurora Kinase A Revenue (2021-2032) & (US$ Million) Table 142. Canada Aurora Kinase A Revenue (2021-2032) & (US$ Million) Table 143. Europe Aurora Kinase A Revenue by Type (2021-2026) & (US$ Million) Table 144. Europe Aurora Kinase A Revenue by Type (2027-2032) & (US$ Million) Table 145. Europe Aurora Kinase A Sales by Type (2021-2026) & (K Units) Table 146. Europe Aurora Kinase A Sales by Type (2027-2032) & (K Units) Table 147. Europe Aurora Kinase A Sales Price by Type (2021-2026) & (US$/Unit) Table 148. Europe Aurora Kinase A Sales Price by Type (2027-2032) & (US$/Unit) Table 149. Europe Aurora Kinase A Revenue by Application (2021-2026) & (US$ Million) Table 150. Europe Aurora Kinase A Revenue by Application (2027-2032) & (US$ Million) Table 151. Europe Aurora Kinase A Sales by Application (2021-2026) & (K Units) Table 152. Europe Aurora Kinase A Sales by Application (2027-2032) & (K Units) Table 153. Europe Aurora Kinase A Sales Price by Application (2021-2026) & (US$/Unit) Table 154. Europe Aurora Kinase A Sales Price by Application (2027-2032) & (US$/Unit) Table 155. Europe Aurora Kinase A Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. Europe Aurora Kinase A Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 157. Europe Aurora Kinase A Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 158. Europe Aurora Kinase A Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 159. Europe Aurora Kinase A Sales by Country (2021-2026) & (K Units) Table 160. Europe Aurora Kinase A Sales by Country (2027-2032) & (K Units) Table 161. Europe Aurora Kinase A Sales Price by Country (2021-2026) & (US$/Unit) Table 162. Europe Aurora Kinase A Sales Price by Country (2027-2032) & (US$/Unit) Table 163. Germany Aurora Kinase A Revenue (2021-2032) & (US$ Million) Table 164. France Aurora Kinase A Revenue (2021-2032) & (US$ Million) Table 165. U.K. Aurora Kinase A Revenue (2021-2032) & (US$ Million) Table 166. Italy Aurora Kinase A Revenue (2021-2032) & (US$ Million) Table 167. Netherlands Aurora Kinase A Revenue (2021-2032) & (US$ Million) Table 168. China Aurora Kinase A Revenue by Type (2021-2026) & (US$ Million) Table 169. China Aurora Kinase A Revenue by Type (2027-2032) & (US$ Million) Table 170. China Aurora Kinase A Sales by Type (2021-2026) & (K Units) Table 171. China Aurora Kinase A Sales by Type (2027-2032) & (K Units) Table 172. China Aurora Kinase A Sales Price by Type (2021-2026) & (US$/Unit) Table 173. China Aurora Kinase A Sales Price by Type (2027-2032) & (US$/Unit) Table 174. China Aurora Kinase A Revenue by Application (2021-2026) & (US$ Million) Table 175. China Aurora Kinase A Revenue by Application (2027-2032) & (US$ Million) Table 176. China Aurora Kinase A Sales by Application (2021-2026) & (K Units) Table 177. China Aurora Kinase A Sales by Application (2027-2032) & (K Units) Table 178. China Aurora Kinase A Sales Price by Application (2021-2026) & (US$/Unit) Table 179. China Aurora Kinase A Sales Price by Application (2027-2032) & (US$/Unit) Table 180. Asia Aurora Kinase A Revenue by Type (2021-2026) & (US$ Million) Table 181. Asia Aurora Kinase A Revenue by Type (2027-2032) & (US$ Million) Table 182. Asia Aurora Kinase A Sales by Type (2021-2026) & (K Units) Table 183. Asia Aurora Kinase A Sales by Type (2027-2032) & (K Units) Table 184. Asia Aurora Kinase A Sales Price by Type (2021-2026) & (US$/Unit) Table 185. Asia Aurora Kinase A Sales Price by Type (2027-2032) & (US$/Unit) Table 186. Asia Aurora Kinase A Revenue by Application (2021-2026) & (US$ Million) Table 187. Asia Aurora Kinase A Revenue by Application (2027-2032) & (US$ Million) Table 188. Asia Aurora Kinase A Sales by Application (2021-2026) & (K Units) Table 189. Asia Aurora Kinase A Sales by Application (2027-2032) & (K Units) Table 190. Asia Aurora Kinase A Sales Price by Application (2021-2026) & (US$/Unit) Table 191. Asia Aurora Kinase A Sales Price by Application (2027-2032) & (US$/Unit) Table 192. Asia Aurora Kinase A Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 193. Asia Aurora Kinase A Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 194. Asia Aurora Kinase A Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 195. Asia Aurora Kinase A Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 196. Asia Aurora Kinase A Sales by Country (2021-2026) & (K Units) Table 197. Asia Aurora Kinase A Sales by Country (2027-2032) & (K Units) Table 198. Asia Aurora Kinase A Sales Price by Country (2021-2026) & (US$/Unit) Table 199. Asia Aurora Kinase A Sales Price by Country (2027-2032) & (US$/Unit) Table 200. Japan Aurora Kinase A Revenue (2021-2032) & (US$ Million) Table 201. South Korea Aurora Kinase A Revenue (2021-2032) & (US$ Million) Table 202. India Aurora Kinase A Revenue (2021-2032) & (US$ Million) Table 203. Australia Aurora Kinase A Revenue (2021-2032) & (US$ Million) Table 204. China Taiwan Aurora Kinase A Revenue (2021-2032) & (US$ Million) Table 205. Southeast Asia Aurora Kinase A Revenue (2021-2032) & (US$ Million) Table 206. SAMEA Aurora Kinase A Revenue by Type (2021-2026) & (US$ Million) Table 207. SAMEA Aurora Kinase A Revenue by Type (2027-2032) & (US$ Million) Table 208. SAMEA Aurora Kinase A Sales by Type (2021-2026) & (K Units) Table 209. SAMEA Aurora Kinase A Sales by Type (2027-2032) & (K Units) Table 210. SAMEA Aurora Kinase A Sales Price by Type (2021-2026) & (US$/Unit) Table 211. SAMEA Aurora Kinase A Sales Price by Type (2027-2032) & (US$/Unit) Table 212. SAMEA Aurora Kinase A Revenue by Application (2021-2026) & (US$ Million) Table 213. SAMEA Aurora Kinase A Revenue by Application (2027-2032) & (US$ Million) Table 214. SAMEA Aurora Kinase A Sales by Application (2021-2026) & (K Units) Table 215. SAMEA Aurora Kinase A Sales by Application (2027-2032) & (K Units) Table 216. SAMEA Aurora Kinase A Sales Price by Application (2021-2026) & (US$/Unit) Table 217. SAMEA Aurora Kinase A Sales Price by Application (2027-2032) & (US$/Unit) Table 218. SAMEA Aurora Kinase A Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 219. SAMEA Aurora Kinase A Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 220. SAMEA Aurora Kinase A Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 221. SAMEA Aurora Kinase A Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 222. SAMEA Aurora Kinase A Sales by Country (2021-2026) & (K Units) Table 223. SAMEA Aurora Kinase A Sales by Country (2027-2032) & (K Units) Table 224. SAMEA Aurora Kinase A Sales Price by Country (2021-2026) & (US$/Unit) Table 225. SAMEA Aurora Kinase A Sales Price by Country (2027-2032) & (US$/Unit) Table 226. Brazil Aurora Kinase A Revenue (2021-2032) & (US$ Million) Table 227. Argentina Aurora Kinase A Revenue (2021-2032) & (US$ Million) Table 228. Chile Aurora Kinase A Revenue (2021-2032) & (US$ Million) Table 229. Colombia Aurora Kinase A Revenue (2021-2032) & (US$ Million) Table 230. Peru Aurora Kinase A Revenue (2021-2032) & (US$ Million) Table 231. Saudi Arabia Aurora Kinase A Revenue (2021-2032) & (US$ Million) Table 232. Israel Aurora Kinase A Revenue (2021-2032) & (US$ Million) Table 233. UAE Aurora Kinase A Revenue (2021-2032) & (US$ Million) Table 234. Turkey Aurora Kinase A Revenue (2021-2032) & (US$ Million) Table 235. Iran Aurora Kinase A Revenue (2021-2032) & (US$ Million) Table 236. Egypt Aurora Kinase A Revenue (2021-2032) & (US$ Million) Table 237. Key Raw Materials Table 238. Raw Materials Key Suppliers Table 239. Aurora Kinase A Distributors List Table 240. Aurora Kinase A Customers List Table 241. Research Programs/Design for This Report Table 242. Authors List of This Report Table 243. Secondary Sources Table 244. Primary Sources List of Figures Figure 1. Aurora Kinase A Image Figure 2. Global Aurora Kinase A Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Aurora Kinase A Market Size Share 2021 VS 2025 VS 2032 Figure 4. AMG-900 Image Figure 5. Ilorasertib Image Figure 6. ENMD-2076 Image Figure 7. Danusertib Image Figure 8. Others Image Figure 9. Global Aurora Kinase A Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Aurora Kinase A Market Size Share 2021 VS 2025 VS 2032 Figure 11. Brain Tumor Image Figure 12. Ovarian Cancer Image Figure 13. Anaplastic Large Cell Lymphoma Image Figure 14. Others Image Figure 15. Global Aurora Kinase A Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Aurora Kinase A Revenue (2021-2032) & (US$ Million) Figure 17. Global Aurora Kinase A Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Aurora Kinase A Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Aurora Kinase A Revenue Market Share by Region (2021-2032) Figure 20. Global Aurora Kinase A Sales (2021-2032) & (K Units) Figure 21. Global Aurora Kinase A Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 22. Global Aurora Kinase A Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Aurora Kinase A Sales YoY (2021-2032) & (K Units) Figure 24. Europe Aurora Kinase A Sales YoY (2021-2032) & (K Units) Figure 25. China Aurora Kinase A Sales YoY (2021-2032) & (K Units) Figure 26. Asia (Excluding China) Aurora Kinase A Sales YoY (2021-2032) & (K Units) Figure 27. South America, Middle East and Africa Aurora Kinase A Sales YoY (2021-2032) & (K Units) Figure 28. Global Aurora Kinase A Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Aurora Kinase A Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Aurora Kinase A Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Aurora Kinase A Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Aurora Kinase A Revenue Market Share by Type (2021-2032) Figure 34. Global Aurora Kinase A Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 35. Global Aurora Kinase A Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Aurora Kinase A Sales Market Share by Type (2021-2032) Figure 37. Global Aurora Kinase A Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Aurora Kinase A Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Aurora Kinase A Revenue Market Share by Application (2021-2032) Figure 40. Global Aurora Kinase A Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 41. Global Aurora Kinase A Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Aurora Kinase A Sales Market Share by Application (2021-2032) Figure 43. North America Aurora Kinase A Revenue Share by Type (2021-2032) Figure 44. North America Aurora Kinase A Sales Share by Type (2021-2032) Figure 45. North America Aurora Kinase A Revenue Share by Application (2021-2032) Figure 46. North America Aurora Kinase A Sales Share by Application (2021-2032) Figure 47. North America Aurora Kinase A Revenue Share by Country (2021-2032) Figure 48. North America Aurora Kinase A Sales Share by Country (2021-2032) Figure 49. Europe Aurora Kinase A Revenue Share by Type (2021-2032) Figure 50. Europe Aurora Kinase A Sales Share by Type (2021-2032) Figure 51. Europe Aurora Kinase A Revenue Share by Application (2021-2032) Figure 52. Europe Aurora Kinase A Sales Share by Application (2021-2032) Figure 53. Europe Aurora Kinase A Revenue Share by Country (2021-2032) Figure 54. Europe Aurora Kinase A Sales Share by Country (2021-2032) Figure 55. China Aurora Kinase A Revenue Share by Type (2021-2032) Figure 56. China Aurora Kinase A Sales Share by Type (2021-2032) Figure 57. China Aurora Kinase A Revenue Share by Application (2021-2032) Figure 58. China Aurora Kinase A Sales Share by Application (2021-2032) Figure 59. Asia Aurora Kinase A Revenue Share by Type (2021-2032) Figure 60. Asia Aurora Kinase A Sales Share by Type (2021-2032) Figure 61. Asia Aurora Kinase A Revenue Share by Application (2021-2032) Figure 62. Asia Aurora Kinase A Sales Share by Application (2021-2032) Figure 63. Asia Aurora Kinase A Revenue Share by Country (2021-2032) Figure 64. Asia Aurora Kinase A Sales Share by Country (2021-2032) Figure 65. SAMEA Aurora Kinase A Revenue Share by Type (2021-2032) Figure 66. SAMEA Aurora Kinase A Sales Share by Type (2021-2032) Figure 67. SAMEA Aurora Kinase A Revenue Share by Application (2021-2032) Figure 68. SAMEA Aurora Kinase A Sales Share by Application (2021-2032) Figure 69. SAMEA Aurora Kinase A Revenue Share by Country (2021-2032) Figure 70. SAMEA Aurora Kinase A Sales Share by Country (2021-2032) Figure 71. Aurora Kinase A Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Aurora Kinase A Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • AMG-900
  • Ilorasertib
  • ENMD-2076
  • Danusertib
  • Others
Applications
  • Brain Tumor
  • Ovarian Cancer
  • Anaplastic Large Cell Lymphoma
  • Others
Companies covered
  • Sanofi
  • Merck & Co., Inc.
  • Amgen Inc.
  • AbbVie Inc.
  • Vichem Chemie Research Ltd.
  • Vertex Pharmaceuticals Incorporated
  • Taiho Pharmaceutical Co., Ltd.
  • Sigma-Tau S.p.A.
  • Sareum Holdings Plc
  • Millennium Pharmaceuticals, Inc.
  • CASI Pharmaceuticals Inc.
  • Astex Pharmaceuticals, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Aurora Kinase A Market by Type
  3. 1.2.1 Global Aurora Kinase A Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 AMG-900
  5. 1.2.3 Ilorasertib
  6. 1.2.4 ENMD-2076
  7. 1.2.5 Danusertib
  8. 1.2.6 Others
  9. 1.3 Aurora Kinase A Market by Application
  10. 1.3.1 Global Aurora Kinase A Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Brain Tumor
  12. 1.3.3 Ovarian Cancer
  13. 1.3.4 Anaplastic Large Cell Lymphoma
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Aurora Kinase A Market Dynamics
  1. 2.1 Aurora Kinase A Industry Trends
  2. 2.2 Aurora Kinase A Industry Drivers
  3. 2.3 Aurora Kinase A Industry Opportunities and Challenges
  4. 2.4 Aurora Kinase A Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Aurora Kinase A Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Aurora Kinase A Revenue by Region
  3. 3.2.1 Global Aurora Kinase A Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Aurora Kinase A Revenue by Region (2021-2026)
  5. 3.2.3 Global Aurora Kinase A Revenue by Region (2027-2032)
  6. 3.2.4 Global Aurora Kinase A Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Aurora Kinase A Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Aurora Kinase A Sales by Region
  9. 3.4.1 Global Aurora Kinase A Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Aurora Kinase A Sales by Region (2021-2026)
  11. 3.4.3 Global Aurora Kinase A Sales by Region (2027-2032)
  12. 3.4.4 Global Aurora Kinase A Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Aurora Kinase A Revenue by Manufacturers
  2. 4.1.1 Global Aurora Kinase A Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Aurora Kinase A Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Aurora Kinase A Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Aurora Kinase A Sales by Manufacturers
  6. 4.2.1 Global Aurora Kinase A Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Aurora Kinase A Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Aurora Kinase A Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Aurora Kinase A Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Aurora Kinase A Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Aurora Kinase A Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Aurora Kinase A Manufacturers, Product Type & Application
  13. 4.7 Global Aurora Kinase A Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Aurora Kinase A Market CR5 and HHI
  16. 4.8.2 2025 Aurora Kinase A Tier 1, Tier 2, and Tier 3
5 Aurora Kinase A Market by Type
  1. 5.1 Global Aurora Kinase A Revenue by Type
  2. 5.1.1 Global Aurora Kinase A Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Aurora Kinase A Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Aurora Kinase A Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Aurora Kinase A Sales by Type
  6. 5.2.1 Global Aurora Kinase A Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Aurora Kinase A Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Aurora Kinase A Sales Market Share by Type (2021-2032)
  9. 5.3 Global Aurora Kinase A Price by Type
6 Aurora Kinase A Market by Application
  1. 6.1 Global Aurora Kinase A Revenue by Application
  2. 6.1.1 Global Aurora Kinase A Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Aurora Kinase A Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Aurora Kinase A Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Aurora Kinase A Sales by Application
  6. 6.2.1 Global Aurora Kinase A Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Aurora Kinase A Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Aurora Kinase A Sales Market Share by Application (2021-2032)
  9. 6.3 Global Aurora Kinase A Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Aurora Kinase A Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Aurora Kinase A Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Merck & Co., Inc.
  8. 7.2.1 Merck & Co., Inc. Company Information
  9. 7.2.2 Merck & Co., Inc. Business Overview
  10. 7.2.3 Merck & Co., Inc. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck & Co., Inc. Aurora Kinase A Product Portfolio
  12. 7.2.5 Merck & Co., Inc. Recent Developments
  13. 7.3 Amgen Inc.
  14. 7.3.1 Amgen Inc. Company Information
  15. 7.3.2 Amgen Inc. Business Overview
  16. 7.3.3 Amgen Inc. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Amgen Inc. Aurora Kinase A Product Portfolio
  18. 7.3.5 Amgen Inc. Recent Developments
  19. 7.4 AbbVie Inc.
  20. 7.4.1 AbbVie Inc. Company Information
  21. 7.4.2 AbbVie Inc. Business Overview
  22. 7.4.3 AbbVie Inc. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 AbbVie Inc. Aurora Kinase A Product Portfolio
  24. 7.4.5 AbbVie Inc. Recent Developments
  25. 7.5 Vichem Chemie Research Ltd.
  26. 7.5.1 Vichem Chemie Research Ltd. Company Information
  27. 7.5.2 Vichem Chemie Research Ltd. Business Overview
  28. 7.5.3 Vichem Chemie Research Ltd. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Vichem Chemie Research Ltd. Aurora Kinase A Product Portfolio
  30. 7.5.5 Vichem Chemie Research Ltd. Recent Developments
  31. 7.6 Vertex Pharmaceuticals Incorporated
  32. 7.6.1 Vertex Pharmaceuticals Incorporated Company Information
  33. 7.6.2 Vertex Pharmaceuticals Incorporated Business Overview
  34. 7.6.3 Vertex Pharmaceuticals Incorporated Aurora Kinase A Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Vertex Pharmaceuticals Incorporated Aurora Kinase A Product Portfolio
  36. 7.6.5 Vertex Pharmaceuticals Incorporated Recent Developments
  37. 7.7 Taiho Pharmaceutical Co., Ltd.
  38. 7.7.1 Taiho Pharmaceutical Co., Ltd. Company Information
  39. 7.7.2 Taiho Pharmaceutical Co., Ltd. Business Overview
  40. 7.7.3 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Product Portfolio
  42. 7.7.5 Taiho Pharmaceutical Co., Ltd. Recent Developments
  43. 7.8 Sigma-Tau S.p.A.
  44. 7.8.1 Sigma-Tau S.p.A. Company Information
  45. 7.8.2 Sigma-Tau S.p.A. Business Overview
  46. 7.8.3 Sigma-Tau S.p.A. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Sigma-Tau S.p.A. Aurora Kinase A Product Portfolio
  48. 7.8.5 Sigma-Tau S.p.A. Recent Developments
  49. 7.9 Sareum Holdings Plc
  50. 7.9.1 Sareum Holdings Plc Company Information
  51. 7.9.2 Sareum Holdings Plc Business Overview
  52. 7.9.3 Sareum Holdings Plc Aurora Kinase A Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Sareum Holdings Plc Aurora Kinase A Product Portfolio
  54. 7.9.5 Sareum Holdings Plc Recent Developments
  55. 7.10 Millennium Pharmaceuticals, Inc.
  56. 7.10.1 Millennium Pharmaceuticals, Inc. Company Information
  57. 7.10.2 Millennium Pharmaceuticals, Inc. Business Overview
  58. 7.10.3 Millennium Pharmaceuticals, Inc. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Millennium Pharmaceuticals, Inc. Aurora Kinase A Product Portfolio
  60. 7.10.5 Millennium Pharmaceuticals, Inc. Recent Developments
  61. 7.11 CASI Pharmaceuticals Inc.
  62. 7.11.1 CASI Pharmaceuticals Inc. Company Information
  63. 7.11.2 CASI Pharmaceuticals Inc. Business Overview
  64. 7.11.3 CASI Pharmaceuticals Inc. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 CASI Pharmaceuticals Inc. Aurora Kinase A Product Portfolio
  66. 7.11.5 CASI Pharmaceuticals Inc. Recent Developments
  67. 7.12 Astex Pharmaceuticals, Inc.
  68. 7.12.1 Astex Pharmaceuticals, Inc. Company Information
  69. 7.12.2 Astex Pharmaceuticals, Inc. Business Overview
  70. 7.12.3 Astex Pharmaceuticals, Inc. Aurora Kinase A Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Astex Pharmaceuticals, Inc. Aurora Kinase A Product Portfolio
  72. 7.12.5 Astex Pharmaceuticals, Inc. Recent Developments
8 North America
  1. 8.1 North America Aurora Kinase A Market Size by Type
  2. 8.1.1 North America Aurora Kinase A Revenue by Type (2021-2032)
  3. 8.1.2 North America Aurora Kinase A Sales by Type (2021-2032)
  4. 8.1.3 North America Aurora Kinase A Price by Type (2021-2032)
  5. 8.2 North America Aurora Kinase A Market Size by Application
  6. 8.2.1 North America Aurora Kinase A Revenue by Application (2021-2032)
  7. 8.2.2 North America Aurora Kinase A Sales by Application (2021-2032)
  8. 8.2.3 North America Aurora Kinase A Price by Application (2021-2032)
  9. 8.3 North America Aurora Kinase A Market Size by Country
  10. 8.3.1 North America Aurora Kinase A Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Aurora Kinase A Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Aurora Kinase A Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Aurora Kinase A Market Size by Type
  2. 9.1.1 Europe Aurora Kinase A Revenue by Type (2021-2032)
  3. 9.1.2 Europe Aurora Kinase A Sales by Type (2021-2032)
  4. 9.1.3 Europe Aurora Kinase A Price by Type (2021-2032)
  5. 9.2 Europe Aurora Kinase A Market Size by Application
  6. 9.2.1 Europe Aurora Kinase A Revenue by Application (2021-2032)
  7. 9.2.2 Europe Aurora Kinase A Sales by Application (2021-2032)
  8. 9.2.3 Europe Aurora Kinase A Price by Application (2021-2032)
  9. 9.3 Europe Aurora Kinase A Market Size by Country
  10. 9.3.1 Europe Aurora Kinase A Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Aurora Kinase A Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Aurora Kinase A Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Aurora Kinase A Market Size by Type
  2. 10.1.1 China Aurora Kinase A Revenue by Type (2021-2032)
  3. 10.1.2 China Aurora Kinase A Sales by Type (2021-2032)
  4. 10.1.3 China Aurora Kinase A Price by Type (2021-2032)
  5. 10.2 China Aurora Kinase A Market Size by Application
  6. 10.2.1 China Aurora Kinase A Revenue by Application (2021-2032)
  7. 10.2.2 China Aurora Kinase A Sales by Application (2021-2032)
  8. 10.2.3 China Aurora Kinase A Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Aurora Kinase A Market Size by Type
  2. 11.1.1 Asia Aurora Kinase A Revenue by Type (2021-2032)
  3. 11.1.2 Asia Aurora Kinase A Sales by Type (2021-2032)
  4. 11.1.3 Asia Aurora Kinase A Price by Type (2021-2032)
  5. 11.2 Asia Aurora Kinase A Market Size by Application
  6. 11.2.1 Asia Aurora Kinase A Revenue by Application (2021-2032)
  7. 11.2.2 Asia Aurora Kinase A Sales by Application (2021-2032)
  8. 11.2.3 Asia Aurora Kinase A Price by Application (2021-2032)
  9. 11.3 Asia Aurora Kinase A Market Size by Country
  10. 11.3.1 Asia Aurora Kinase A Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Aurora Kinase A Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Aurora Kinase A Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Aurora Kinase A Market Size by Type
  2. 12.1.1 SAMEA Aurora Kinase A Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Aurora Kinase A Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Aurora Kinase A Price by Type (2021-2032)
  5. 12.2 SAMEA Aurora Kinase A Market Size by Application
  6. 12.2.1 SAMEA Aurora Kinase A Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Aurora Kinase A Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Aurora Kinase A Price by Application (2021-2032)
  9. 12.3 SAMEA Aurora Kinase A Market Size by Country
  10. 12.3.1 SAMEA Aurora Kinase A Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Aurora Kinase A Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Aurora Kinase A Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Aurora Kinase A Value Chain Analysis
  2. 13.1.1 Aurora Kinase A Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Aurora Kinase A Production Mode & Process
  6. 13.2 Aurora Kinase A Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Aurora Kinase A Distributors
  9. 13.2.3 Aurora Kinase A Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst